Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Abituzumab (DB12775)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01008475EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerTreatment